💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 513 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$10.7B
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 4/6 (Toplam: 513)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | $203.24M | $3.65 | 5.80% |
| OABI | OmniAb, Inc. | $194.80M | $1.81 | 2.69% |
| RNAC | Cartesian Therapeutics, Inc. | $194.77M | $7.49 | 1.45% |
| CCCC | C4 Therapeutics, Inc. | $192.89M | $2.71 | 1.12% |
| HUMA | Humacyte, Inc. | $192.80M | $1.35 | 1.50% |
| MXCT | MaxCyte, Inc. | $187.75M | $1.76 | 0.57% |
| DERM | Journey Medical Corporation | $186.01M | $8.07 | 3.07% |
| LFMD | LifeMD, Inc. | $184.36M | $3.83 | 0.26% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $184.19M | $6.79 | 0.15% |
| HRTX | Heron Therapeutics, Inc. | $183.21M | $1.16 | 3.57% |
| UTMD | Utah Medical Products, Inc. | $180.53M | $56.35 | 1.22% |
| CATX | Perspective Therapeutics, Inc. | $174.66M | $2.35 | 5.38% |
| SLS | SELLAS Life Sciences Group, Inc. | $172.34M | $1.64 | 11.99% |
| VTGN | VistaGen Therapeutics, Inc. | $160.59M | $4.90 | 7.93% |
| NVCT | Nuvectis Pharma, Inc. | $159.80M | $6.24 | 2.97% |
| MCRB | Seres Therapeutics, Inc. | $157.86M | $17.99 | 6.64% |
| SAVA | Cassava Sciences, Inc. | $157.53M | $3.26 | 3.81% |
| CHRS | Coherus BioSciences, Inc. | $157.06M | $1.35 | 3.44% |
| SGMO | Sangamo Therapeutics, Inc. | $155.29M | $0.46 | 0.56% |
| AGEN | Agenus Inc. | $154.59M | $4.56 | 0.22% |
| SCLX | Scilex Holding Company | $154.48M | $20.36 | 0.12% |
| ANIX | Anixa Biosciences, Inc. | $151.07M | $4.59 | 1.08% |
| CDXS | Codexis, Inc. | $146.75M | $1.73 | 0.57% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $144.66M | $11.54 | 2.86% |
| ANIK | Anika Therapeutics, Inc. | $143.92M | $9.98 | 1.11% |
| IMMX | Immix Biopharma, Inc. | $142.69M | $4.25 | 1.16% |
| TNXP | Tonix Pharmaceuticals Holding Corp. | $139.99M | $15.97 | 5.90% |
| ISPR | Ispire Technology Inc. | $139.62M | $2.44 | 0.41% |
| MRSN | Mersana Therapeutics, Inc. | $137.12M | $27.43 | 0.40% |
| SPRO | Spero Therapeutics, Inc. | $135.20M | $2.40 | 3.00% |
| NKTX | Nkarta, Inc. | $133.89M | $1.89 | 3.01% |
| ALEC | Alector, Inc. | $133.79M | $1.33 | 1.11% |
| FATE | Fate Therapeutics, Inc. | $131.47M | $1.14 | 3.64% |
| OVID | Ovid Therapeutics Inc. | $126.59M | $1.78 | 9.20% |
| GLSI | Greenwich LifeSciences, Inc. | $120.85M | $8.73 | 4.55% |
| ORMP | Oramed Pharmaceuticals Inc. | $118.75M | $2.85 | 0.00% |
| RANI | Rani Therapeutics Holdings, Inc. | $116.79M | $1.60 | 1.23% |
| ABOS | Acumen Pharmaceuticals, Inc. | $113.88M | $1.88 | 3.59% |
| GUTS | Fractyl Health, Inc. Common Stock | $113.34M | $1.57 | 6.08% |
| INO | Inovio Pharmaceuticals, Inc. | $110.40M | $2.06 | 5.10% |
| ATRA | Atara Biotherapeutics, Inc. | $108.86M | $15.10 | 1.62% |
| COYA | Coya Therapeutics, Inc. | $108.17M | $6.51 | 2.04% |
| HLVX | HilleVax, Inc. | $104.76M | $2.09 | 0.48% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $103.32M | $1.43 | 0.69% |
| CNTX | Context Therapeutics Inc. | $102.90M | $1.12 | 0.89% |
| STTK | Shattuck Labs, Inc. | $100.60M | $2.10 | 1.41% |
| ATOS | Atossa Therapeutics, Inc. | $100.43M | $0.78 | 0.29% |
| ANVS | Annovis Bio, Inc. | $100.34M | $5.10 | 3.66% |
| PLRX | Pliant Therapeutics, Inc. | $98.32M | $1.60 | 1.27% |
| ELDN | Eledon Pharmaceuticals, Inc. | $97.72M | $1.63 | 5.16% |
| OPTN | OptiNose, Inc. | $97.22M | $9.60 | 0.00% |
| MGNX | MacroGenics, Inc. | $96.79M | $1.53 | 3.38% |
| PRLD | Prelude Therapeutics Incorporated | $92.71M | $1.68 | 0.60% |
| ARTV | Artiva Biotherapeutics, Inc. | $92.29M | $3.76 | 5.03% |
| CRVO | CervoMed Inc. | $91.97M | $9.94 | 0.00% |
| THAR | Tharimmune, Inc. | $91.12M | $2.60 | 1.56% |
| ADVM | Adverum Biotechnologies, Inc. | $90.96M | $4.12 | 0.96% |
| VXRT | Vaxart, Inc. | $88.82M | $0.37 | 2.78% |
| TVGN | Tevogen Bio Holdings Inc. | $87.66M | $0.44 | 8.27% |
| FBIO | Fortress Biotech, Inc. | $87.52M | $2.82 | 2.17% |
| TIL | Instil Bio, Inc. | $86.50M | $12.76 | 6.47% |
| VRCA | Verrica Pharmaceuticals Inc. | $86.36M | $9.10 | 35.62% |
| BYSI | BeyondSpring Inc. | $85.50M | $2.12 | 1.44% |
| XTNT | Xtant Medical Holdings, Inc. | $82.17M | $0.59 | 5.51% |
| CAMP | CAMP4 Therapeutics Corporation | $80.71M | $3.80 | 4.97% |
| VANI | Vivani Medical, Inc. | $80.35M | $1.36 | 0.00% |
| OTLK | Outlook Therapeutics, Inc. | $79.51M | $1.79 | 6.55% |
| STRO | Sutro Biopharma, Inc. | $78.26M | $0.92 | 3.73% |
| IGMS | IGM Biosciences, Inc. | $77.50M | $1.27 | 0.00% |
| ATYR | aTyr Pharma, Inc. | $76.64M | $0.78 | 2.21% |
| IPA | ImmunoPrecise Antibodies Ltd. | $74.77M | $1.62 | 2.53% |
| ACRV | Acrivon Therapeutics, Inc. Common Stock | $74.47M | $2.36 | 0.00% |
| ALXO | ALX Oncology Holdings Inc. | $74.28M | $1.37 | 0.72% |
| DTIL | Precision BioSciences, Inc. | $72.11M | $5.44 | 6.46% |
| MNOV | MediciNova, Inc. | $71.12M | $1.45 | 0.00% |
| ASRT | Assertio Holdings, Inc. | $70.97M | $0.74 | 1.96% |
| IMUX | Immunic, Inc. | $70.25M | $0.71 | 1.55% |
| PMVP | PMV Pharmaceuticals, Inc. | $70.24M | $1.32 | 1.49% |
| VTVT | vTv Therapeutics Inc. | $69.38M | $26.51 | 1.81% |
| XBIT | XBiotech Inc. | $69.36M | $2.27 | 0.22% |
| MGX | Metagenomi, Inc. Common Stock | $65.71M | $1.75 | 3.55% |
| LPTX | Leap Therapeutics, Inc. | $63.54M | $1.53 | 9.17% |
| OSTX | OS Therapies Incorporated | $63.03M | $1.79 | 3.24% |
| TCRX | TScan Therapeutics, Inc. | $63.00M | $1.11 | 0.00% |
| SNTI | Senti Biosciences, Inc. | $58.62M | $2.23 | 5.69% |
| SPRB | Spruce Biosciences, Inc. | $58.03M | $100.00 | 9.09% |
| VOR | Vor Biopharma Inc. | $56.96M | $8.31 | 4.53% |
| ACET | Adicet Bio, Inc. | $53.98M | $0.65 | 7.85% |
| KRON | Kronos Bio, Inc. | $53.65M | $0.88 | 1.49% |
| KRRO | Korro Bio, Inc. | $53.45M | $5.70 | 3.26% |
| BCAB | BioAtla, Inc. | $53.15M | $0.90 | 6.27% |
| CVM | CEL-SCI Corporation | $52.67M | $7.67 | 2.06% |
| CUE | Cue Biopharma, Inc. | $49.60M | $0.63 | 0.67% |
| INKT | MiNK Therapeutics, Inc. | $49.34M | $10.51 | 5.82% |
| BTAI | BioXcel Therapeutics, Inc. | $49.21M | $2.25 | 8.17% |
| BLUE | bluebird bio, Inc. | $48.67M | $4.97 | 0.00% |
| HOWL | Werewolf Therapeutics, Inc. | $48.53M | $1.00 | 2.35% |
| KPTI | Karyopharm Therapeutics Inc. | $47.98M | $5.62 | 1.26% |
| CELU | Celularity Inc. | $47.75M | $1.99 | 0.25% |
| INMB | INmune Bio, Inc. | $46.26M | $1.74 | 5.45% |